<DOC>
	<DOCNO>NCT01034020</DOCNO>
	<brief_summary>Background : - Many cigarette smoker claim smoking help stay alert improves concentration , report problem attention concentration quit smoking . Some research indicate nicotine enhance certain aspect attention memory human . However , research need determine nicotine affect different element brain 's ability pay attention . Knowing aspect attention affect nicotine may help produce new medication therapy help people successfully stop smoking . Objectives : - To investigate dose-related effect nicotine ability pay attention smoker nonsmoker . - To compare effect nicotine smoker nonsmoker . Eligibility : - Individuals 18 50 year age either current smoker ( least 15 cigarette per day average least 2 year ) healthy , nonsmoking volunteer . Design : - The study consist one training session three test session . Each session last 2 hour . - The training session introduce participant study test evaluate tolerance two level nicotine nasal spray use study . Smokers receive high dose nicotine introduce effect spray . Nonsmokers give first low dose spray , follow high dose least 30 minute later . Nonsmoking participant tolerate high dose continue study . - At start test session , smoker one cigarette standardize time recent exposure nicotine . - During test session , participant receive placebo spray , low dose nicotine , high dose nicotine , ask perform test evaluate mood , attention , performance .</brief_summary>
	<brief_title>Effects Nicotine Elements Attentions Smokers Nonsmokers</brief_title>
	<detailed_description>Objective : The primary objective study investigate dose-related effect nicotine various element attention smoker nonsmoker . Because publish study , knowledge , report effect nicotine ANT ABT , include CPT , task show sensitive nicotine , positive control . A secondary aim compare subjective physiological effect nicotine smoker nonsmoker . Study Population : 50 smoker total 30 completers ( 15 woman , 15 men ) 50 nonsmoker total 30 completers ( 15 woman , 15 men ) . Design : Placebo-controlled , between-groups comparison smoker nonsmoker . Participants attend three experiemental session ; single dose nicotine nasal spray ( 0 , 0.5 , 1.5 mg ) administer session . Outcome Measures : Primary outcome measure accuracy and/or response time three attention test , ANT , CPT , ABT . Secondary outcome measure include response PANAS , VAS item , vital sign ( heart rate blood pressure ) . Participant demographic smoke history report use descriptive statistic .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>INCLUSION CRITERIA : Smokers 1. men woman 1850 year old 2. report smoke least 15 cigarette per day average least 2 year 3. urine cotinine level great equl 200 ng/ml 4. estimate IQ score great equal 85 5. medically psychologically healthy determine screen criterion EXCLUSION CRITERIA : Smokers 1. interested reduce quit tobacco use 2. treated nicotine dependence past 3 month 3 ) report history drug alcohol dependence 4 ) report consumption 15 alcoholic drink per week past month 5 ) report use marijuana per week past month 6 ) report use illicit drug , marijuana , past 6 month 7 ) currently use medication would interfere protocol 8 ) influence drug alcohol experimental session 9 ) pregnant nursing 10 ) HIV positive . INCLUSION CRITERIA : Nonsmokers 1. men woman 1850 year old 2. report smoke less 10 cigarette life 3. urine cotinine level le 30 ng/ml 4. estimate IQ score great equal 85 5. medically psychologically healthy determine screen criterion EXCLUSION CRITERIA : Nonsmokers 1. report use tobacco product past 3 year 2. report history drug alcohol dependence 3. report consumption 15 alcoholic drink per week past month 4. report use marijuana per week past month 5. report use illicit drug , marijuana , past 6 month 6. currently use medication would interfere protocol 7. influence drug alcohol experimental session 8. pregnant nursing 9. HIV positive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 22, 2010</verification_date>
	<keyword>Nasal Spray</keyword>
	<keyword>Attention Network Test</keyword>
	<keyword>Continuous Performance Test</keyword>
	<keyword>Attentional Blink Test</keyword>
</DOC>